Regentis Biomaterials (RGNT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.49, -3.87% vs the prior close of $1.55.
- Volume 23.49K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RGNT slides 3.9% to $1.49, a 3-month low. Closed at $1.49, -3.87% vs the prior close of $1.55. Day range $1.46–$1.60, opened at $1.60.
RGNT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RGNT slides 3.9% to $1.49, a 3-month low
- Closed at $1.49, -3.87% vs the prior close of $1.55. Day range $1.46–$1.60, opened at $1.60.
- Volume was 23.49K shares, 0.5x its 50-day average of 50.18K — lighter than usual.
- Price is -21.5% vs its 50-day average ($1.90) and -53.2% vs its 200-day average ($3.18).
- 52-week range $1.23–$15.50; today's close sits at 2% of that range, 90.4% below the 52-week high.
Oct 15, 2026 — RGNT rises 2.6% to $1.55
- Closed at $1.55, +2.65% vs the prior close of $1.51. Day range $1.50–$1.56, opened at $1.55.
- Volume was 14.30K shares, 0.3x its 50-day average of 52.14K — lighter than usual.
- Price is -18.8% vs its 50-day average ($1.91) and -51.7% vs its 200-day average ($3.21).
- 52-week range $1.23–$15.50; today's close sits at 2% of that range, 90.0% below the 52-week high.
Oct 14, 2026 — RGNT slides 7.1% to $1.51, a 3-month low on 2.6x normal volume
- Closed at $1.51, -7.08% vs the prior close of $1.62. Day range $1.45–$1.65, opened at $1.65.
- Volume was 132.60K shares, 2.6x its 50-day average of 51.81K — unusually heavy trading.
- Price is -21.3% vs its 50-day average ($1.92) and -53.4% vs its 200-day average ($3.24).
- 52-week range $1.23–$15.50; today's close sits at 2% of that range, 90.3% below the 52-week high.
Oct 13, 2026 — RGNT dips 0.3% to $1.62
- Closed at $1.62, -0.31% vs the prior close of $1.63. Day range $1.59–$1.67, opened at $1.63.
- Volume was 33.40K shares, 0.6x its 50-day average of 54.07K.
- Price is -15.8% vs its 50-day average ($1.93) and -50.2% vs its 200-day average ($3.27).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — RGNT rises 1.9% to $1.63
- Closed at $1.63, +1.87% vs the prior close of $1.60. Day range $1.60–$1.64, opened at $1.62.
- Volume was 36.10K shares, 0.6x its 50-day average of 55.92K.
- Price is -15.8% vs its 50-day average ($1.93) and -50.5% vs its 200-day average ($3.29).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.5% below the 52-week high.
Oct 9, 2026 — RGNT slides 5.9% to $1.60, a 3-month low
- Closed at $1.60, -5.88% vs the prior close of $1.70. Day range $1.60–$1.74, opened at $1.67.
- Volume was 22.20K shares, 0.4x its 50-day average of 56.84K — lighter than usual.
- Price is -17.4% vs its 50-day average ($1.94) and -51.8% vs its 200-day average ($3.32).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.7% below the 52-week high.
Oct 8, 2026 — RGNT jumps 4.3% to $1.70 on 3.2x normal volume
- Closed at $1.70, +4.29% vs the prior close of $1.63. Day range $1.65–$1.73, opened at $1.69.
- Volume was 172.80K shares, 3.2x its 50-day average of 54.45K — unusually heavy trading.
- Price is -12.4% vs its 50-day average ($1.94) and -49.1% vs its 200-day average ($3.34).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.0% below the 52-week high.
Oct 7, 2026 — RGNT dips 1.2% to $1.63, a 3-month low, 3 down days in a row
- Closed at $1.63, -1.21% vs the prior close of $1.65. Day range $1.63–$1.69, opened at $1.64.
- Volume was 17.00K shares, 0.3x its 50-day average of 56.53K — lighter than usual.
- Price is -16.1% vs its 50-day average ($1.94) and -51.5% vs its 200-day average ($3.36).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.5% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — RGNT dips 1.2% to $1.65, a 3-month low
- Closed at $1.65, -1.20% vs the prior close of $1.67. Day range $1.65–$1.74, opened at $1.67.
- Volume was 34.00K shares, 0.6x its 50-day average of 57.20K — lighter than usual.
- Price is -15.2% vs its 50-day average ($1.95) and -51.3% vs its 200-day average ($3.39).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.4% below the 52-week high.
Oct 5, 2026 — RGNT slides 9.7% to $1.67, a 3-month low on 1.9x normal volume
- Closed at $1.67, -9.73% vs the prior close of $1.85. Day range $1.66–$1.86, opened at $1.83.
- Volume was 109.50K shares, 1.9x its 50-day average of 56.45K — unusually heavy trading.
- Price is -14.5% vs its 50-day average ($1.95) and -51.0% vs its 200-day average ($3.41).
- 52-week range $1.23–$15.50; today's close sits at 3% of that range, 89.2% below the 52-week high.
Oct 2, 2026 — RGNT rises 1.1% to $1.85
- Closed at $1.85, +1.09% vs the prior close of $1.83. Day range $1.78–$1.87, opened at $1.85.
- Volume was 29.00K shares, 0.5x its 50-day average of 56.74K — lighter than usual.
- Price is -5.6% vs its 50-day average ($1.96) and -46.1% vs its 200-day average ($3.43).
- 52-week range $1.23–$15.50; today's close sits at 4% of that range, 88.1% below the 52-week high.
RGNT latest news & SEC filings
Every SEC filing by or about RGNT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Sep 17, 2026 · Form POS AM — POS AM filing
POS AM filing
Sep 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade RGNT
- How much it moves: over the last 20 sessions the average daily move was 4.24% (largest 23.2%). That is a volatile stock.
- Liquidity: about 63.03K shares (≈$93.92K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.49 vs a range of $1.23–$15.50 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 13, 2026; 6-K Sep 11, 2026; 6-K Jul 20, 2026.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
RGNT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.60 | 1.60 | 1.46 | 1.49 | 23.49K |
| Oct 15, 2026 | 1.55 | 1.56 | 1.50 | 1.55 | 14.30K |
| Oct 14, 2026 | 1.65 | 1.65 | 1.45 | 1.51 | 132.60K |
| Oct 13, 2026 | 1.63 | 1.67 | 1.59 | 1.62 | 33.40K |
| Oct 12, 2026 | 1.62 | 1.64 | 1.60 | 1.63 | 36.10K |
| Oct 9, 2026 | 1.67 | 1.74 | 1.60 | 1.60 | 22.20K |
| Oct 8, 2026 | 1.69 | 1.73 | 1.65 | 1.70 | 172.80K |
| Oct 7, 2026 | 1.64 | 1.69 | 1.63 | 1.63 | 17.00K |
| Oct 6, 2026 | 1.67 | 1.74 | 1.65 | 1.65 | 34.00K |
| Oct 5, 2026 | 1.83 | 1.86 | 1.66 | 1.67 | 109.50K |
| Oct 2, 2026 | 1.85 | 1.87 | 1.78 | 1.85 | 29.00K |
| Oct 1, 2026 | 1.86 | 1.88 | 1.80 | 1.83 | 9.00K |
| Sep 30, 2026 | 1.87 | 1.98 | 1.81 | 1.81 | 22.20K |
| Sep 29, 2026 | 1.92 | 1.92 | 1.80 | 1.85 | 58.60K |
| Sep 28, 2026 | 1.95 | 1.97 | 1.86 | 1.89 | 7.60K |
| Sep 25, 2026 | 2.06 | 2.08 | 1.90 | 1.98 | 17.20K |
| Sep 24, 2026 | 2.08 | 2.08 | 2.00 | 2.04 | 25.00K |
| Sep 23, 2026 | 2.13 | 2.15 | 2.05 | 2.10 | 15.10K |
| Sep 22, 2026 | 2.17 | 2.17 | 2.09 | 2.09 | 41.20K |
| Sep 21, 2026 | 1.85 | 2.48 | 1.85 | 2.23 | 440.40K |
About Regentis Biomaterials
Regentis Biomaterials (RGNT) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in OR AKIVA. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1912966.
RGNT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Susan Phd Md Alpert | Director | Jul 13, 2026 |
| Pini Ben-Elazar | Director | Jul 13, 2026 |
| Efraim Cohen-Arazi | Director | Jul 13, 2026 |
| Jeff Dykan | Director | Jul 13, 2026 |
| Ehud Geller | Chief Executive Officer | Jul 13, 2026 |
| Keith Valentine | Director | Jul 13, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ehud Geller | Chief Executive Officer | Jul 13, 2026 |
| Ori Gon | Chief Financial Officer | Mar 18, 2026 |
| Arie Gordashnikov | Chief Accounting Officer | Mar 18, 2026 |
| Galit Reske | Chief Medical Officer | Mar 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RGNT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
RGNT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RGNT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.